← All trials
NCT01423032
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2001
- Primary completion
- May 1, 2009
- Completion date
- May 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 96
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- WiSP GmbHLead sponsor
- MundipharmaCollaborator
- Med. Klinik III, Klinikum Leverkusen gGmbH, GermanyStudy chair
- Klinikum Leverkusen gGmbHCollaborator
- HikmaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.